
H Lundbeck raises 2026 forecasts on US demand, delayed generic competition
May 12 (Reuters) - Danish drugmaker H Lundbeck raised its 2026 sales and earnings growth forecasts o...
12th May, 2026

May 12 (Reuters) - Danish drugmaker H Lundbeck raised its 2026 sales and earnings growth forecasts o...
12th May, 2026
ZURICH, May 12 (Reuters) - Swiss drugmaker Roche has received the CE mark - a European regulatory cl...
12th May, 2026
May 5 (Reuters) - Swiss drugmaker Novartis said on Tuesday that it is set to cut around 220 jobs in...
5th May, 2026

By Marleen Kaesebier BASEL, Switzerland, May 5 (Reuters) - Switzerland's biotech industry shifted to...
5th May, 2026
April 28 (Reuters) - Swiss drugmaker Novartis reported first-quarter core operating profit and sales...
28th April, 2026
By Sriparna Roy April 24 (Reuters) - Eli Lilly's newly launched weight-loss pill had a modest second...
24th April, 2026
By Maggie Fick and Bhanvi Satija BARCELONA, April 23 (Reuters) - Europe risks falling further behind...
23rd April, 2026
April 23 (Reuters) - Novo Nordisk's oral GLP-1 drug met the main goal of a late-stage study in child...
23rd April, 2026

April 23 (Reuters) - Hikma Pharmaceuticals reiterated its 2026 guidance on Thursday, adding that whi...
23rd April, 2026
LONDON, April 23 (Reuters) - French drugmaker Sanofi on Thursday reported first-quarter profit and r...
23rd April, 2026
By Maggie Fick BARCELONA, April 22 (Reuters) - European Union authorities need a broader remit to se...
22nd April, 2026
By Andrew Silver SHANGHAI, April 22 (Reuters) - Pfizer’s GLP-1 weight management treatment Xianweiyi...
22nd April, 2026